Vitrium Clinical Study

Bio2 Technologies, Inc. Receives FDA IDE Approval to Begin Clinical Study of Resorbable Cervical Interbody Device for Spinal Fusion

WOBURN, Mass., Nov. 13, 2018 /PRNewswire/ — Bio2 Technologies, Inc., a privately held orthopedics company, announced today that it received U.S. Food and…